| A brief synthesis of (−)-englerin A Z Li, M Nakashige, WJ Chain Journal of the American Chemical Society 133 (17), 6553-6556, 2011 | 145 | 2011 |
| Heterocyclic compounds as immunomodulators L Wu, B Shen, J Li, Z Li, K Liu, F Zhang, W Yao US Patent App. 15/296,234, 2017 | 99 | 2017 |
| The cytotoxicity of (−)-lomaiviticin A arises from induction of double-strand breaks in DNA LC Colis, CM Woo, DC Hegan, Z Li, PM Glazer, SB Herzon Nature chemistry 6 (6), 504-510, 2014 | 97 | 2014 |
| Heterocyclic compounds as immunomodulators Z Li, L Wu, W Yao US Patent App. 15/587,466, 2017 | 96 | 2017 |
| Heterocyclic compounds as immunomodulators L Wu, DQ Qian, L Lu, N Lajkiewicz, LC Konkol, Z Li, F Zhang, J Li, ... US Patent App. 15/851,280, 2018 | 90 | 2018 |
| Heterocyclic compounds as immunomodulators L Wu, N Lajkiewicz, C He, K Xiao, W Zhu, Z Li, S Mei, C Qi, LC Konkol, ... US Patent App. 15/850,985, 2018 | 87 | 2018 |
| Heterocyclic compounds as immunomodulators L Wu, B Shen, J Li, Z Li, K Liu, F Zhang, W Yao US Patent App. 16/005,961, 2019 | 75 | 2019 |
| Heterocyclic compounds as immunomodulators Z Li, L Wu, W Yao US Patent App. 15/906,655, 2019 | 71 | 2019 |
| Englerin A Selectively Induces Necrosis in Human Renal Cancer Cells FJ Sulzmaier, Z Li, ML Nakashige, DM Fash, WJ Chain, JW Ramos PloS one 7 (10), e48032, 2012 | 52 | 2012 |
| Development of Enantioselective Synthetic Routes to (−)-Kinamycin F and (−)-Lomaiviticin Aglycon CM Woo, SL Gholap, L Lu, M Kaneko, Z Li, PC Ravikumar, SB Herzon Journal of the American Chemical Society 134 (41), 17262-17273, 2012 | 52 | 2012 |
| Total synthesis of plakortide e and biomimetic synthesis of plakortone b XY Sun, XY Tian, ZW Li, XS Peng, HNC Wong Chemistry-A European Journal 17 (21), 5874-5880, 2011 | 49 | 2011 |
| Englerins: A Comprehensive Review Z Wu, S Zhao, DM Fash, Z Li, WJ Chain, JA Beutler Journal of Natural Products 80 (3), 771-781, 2017 | 48 | 2017 |
| Total synthesis of (±)-pallambins C and D XS Xu, ZW Li, YJ Zhang, XS Peng, HNC Wong Chemical Communications 48 (68), 8517-8519, 2012 | 40 | 2012 |
| Heterocyclic compounds as LSD1 inhibitors C He, Z Li, L Wu, W Yao, F Zhang US Patent 9,944,647, 2018 | 36 | 2018 |
| Structural basis for DNA cleavage by the potent antiproliferative agent (–)-lomaiviticin A CM Woo, Z Li, EK Paulson, SB Herzon Proceedings of the National Academy of Sciences 113 (11), 2851-2856, 2016 | 30 | 2016 |
| Heterocyclic compounds as immunomodulators Z Li, L Wu, W Yao US Patent App. 16/781,927, 2020 | 28 | 2020 |
| Construction of metal-organic frameworks through coordination and hydrogen bonding interactions: Syntheses, structures and photoluminescent properties of metal complexes with … XM Ouyang, ZW Li, T Okamura, YZ Li, WY Sun, WX Tang, N Ueyama Journal of Solid State Chemistry 177 (1), 350-360, 2004 | 28 | 2004 |
| Heterocyclic compounds as immunomodulators L Wu, J Li, W Yao, C Qi, DQ Qian, F Zhang US Patent 11,339,149, 2022 | 26 | 2022 |
| Heterocyclic compounds as immunomodulators Z Li, L Wu, W Yao US Patent 11,608,337, 2023 | 25 | 2023 |
| Heterocyclic compounds as LSD1 inhibitors C He, Z Li, L Wu, W Yao, F Zhang US Patent 10,800,779, 2020 | 20 | 2020 |
